LBRX Stock: Price, Earnings History and SEC Filings
LB Pharmaceuticals Inc (LBRX) last traded at $39.70, down 1.12% on the latest session and up 3.4% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-1.71 against an analyst estimate of $-0.84, a miss of 103.6%.
$39.70 -1.12%
1 month+3.44%
52-week high$50.16
52-week low$14.32
Volume429,474
ExchangeNasdaqGM
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
LBRX earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 11, 2026 | $-1.71 | $-0.84 | -103.57% |
| Mar 2026 | May 12, 2026 | $-0.67 | $-0.75 | +10.67% |
| Dec 2025 | Mar 26, 2026 | $-0.45 | $-0.45 | +0.00% |
| Sep 2025 | Nov 6, 2025 | $-0.61 | $-0.57 | -7.02% |
LBRX beat the analyst EPS estimate in 1 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for LBRX
SEC filing data is not available right now. You can search for LBRX on SEC EDGAR.
LBRX news
- Guggenheim names LB Pharmaceuticals a top idea ahead of pivotal trial dataOct 28, 2026 · finance.yahoo.com
- LB Pharmaceuticals Eyes 2027 Phase III Data for LB-102 in SchizophreniaOct 28, 2026 · marketbeat.com
About LB Pharmaceuticals Inc
LB Pharmaceuticals Inc (LBRX) is a US-listed public company on Nasdaq.